The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Approves Oral Semaglutide as the First Oral GLP 1 Pill An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica 2026 FDA Peptide Reclassification Purefico Medspa and Therapy